Speaker Profile
Biography
Catriona Jamieson is a leading physician scientist who has specialized inmyeloproliferative neoplasms (MP Ns) and leukemia. She discoveredmissplicing, RNA hyperediting, and splice isoform switching as mechanismsgoverning human cancer stem cell maintenance in selective niches. Thesediscoveries have helped to shed light on the underlying mechanisms of cancer and have opened up new avenues for targeted therapies. Dr. Jamieson's contributions to the field of precision medicine include herpivotal role in the rescue and development of the JAK inhibitor fedratinibfor the treatment of myelofibrosis. Additionally, she is known for herunwavering dedication to advancing innovative therapies and her outst and ingleadership as the director of the Sanford Stem Cell Institute at UCSD andas a co-founder of Impact Biosciences and Aspera Biomedicines.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Catriona Jamieson, UCSD
Opening talk
• Catriona Jamieson, UCSD
PMWC Award Ceremony
• Judy Faulkner, Epic
• Alexis C. Komor, UCSD
What’s Next at Epic?
• Peter DeVault, Epic
RNA Therapeutics Beyond mRNA: siRNA, ASOs, and snRNA
• Chair: Alexis C. Komor, UCSD
• Niren Murthy, UC Berkeley
• Gene Yeo, UCSD
• Reuben Harris, UT Health San Antonio
Small Molecule Therapeutics Targeting Stem Cells
• Chair: Catriona Jamieson, UCSD
• Irving L. Weissman, Stanford
Space-Omics & Stem-Cell Adaptation
• Chair: Catriona Jamieson, UCSD
• Alysson Muotri, UCSD
In Vivo Gene Therapies
• Chair: Gene Yeo, UCSD
• Mark A Kay, Stanford
• David Schaffer, UC Berkeley
Diagnostics, Prognostics, and Patient Stratification
• Chair: Ezra Cohen, Tempus
• Gudrun Stengel, Alida Biosciences
• David Ledbetter, Florida State University
Bioprinting Transplantable Liver: mRNA-Driven Multi-Lineage Differentiation from Autologous iPSCs
• Jiwu Wang, The Scintillon Institute
A New Era in Heart Failure Treatment: Delivering on the Promise of iPSC-Derived Cardiomyocyte Therapy
• Eugene Wang, Help Therapeutics
Closing Talk
• Catriona Jamieson, UCSD




